HIMSS signs national partnership with Netics to evaluate EMR adoption of Italian healthcare providers

Berlin, 19th May 2015: HIMSS Europe has signed a national partnership agreement with Nectics to improve the level of digital maturity in healthcare organizations across Italy.

HIMSS Europe will work with Netics to provide its Electronic Medical Record Adoption Model (EMRAM), which tracks healthcare organizations' progress towards achieving a paperless patient record environment. Hospitals and ambulatory care facilities are scored based on their level of an EMR adoption from Stage 0 through Stage 7.
 
Jörg Studzinski, Senior Consultant at HIMSS Analytics Europe said: “The signed partnership with Netics aims to bring together the two healthcare activities that each entity does best:  the HIMSS EMRAM, a globally recognised model that analyzes digital maturity and highlights the benefits achieved by the adoption of IT in the healthcare sector,  and the strong Italian healthcare knowledge which Netics holds.”
 
The early stages of the partnership will see acute public and private hopsitals across Italy  complete the EMRAM survey, which will subsequently enable Chief Information Officers (CIOs) to compare the effectiveness of their digital maturity with their peers and to strategize their path to a complete EMR which enables more financial and clinical benefits.

AISIS (Italian Association of Information Systems in Health), an organization that aims to give visibility to those who are professionally involved in ICT and to raise the profile of issues related to the use of ICT in healthcare as a strategic lever for change, will also work with HIMSS to distribute the EMRAM survey among CIOs across the country and collate their feedback.

Claudio Caccia, President of AISIS said: “The decision to adopt EMRAM as a tool for benchmarking information systems across Italian healthcare system is due to an increased focus by AISIS and Netics in recent years to better understand the value of information systems in health care while providing comparisons at an international level.”

Paolo Colli Franzone, Director, Netics, added: ““We are honored that HIMSS has chosen to collaborate with us as an Italian partner, recognizing the strong competence which distinguishes us in the eHealth consulting market.”

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.